Načítá se...

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange

The evidence for conversion from brand name to generic equivalent cyclosporine is conflicting. Cyclosporine is a narrow therapeutic-range drug for which small variations in exposure may have severe clinical consequences for transplant patients. There is currently a lack of comparative outcome data r...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Singh, A. K., Narsipur, S. S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3235899/
https://ncbi.nlm.nih.gov/pubmed/22174986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/480642
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!